Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolia in periprosthetic osteolysis of the hip
NCT01358669Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Dec 2011
- Primary completion
- Jan 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in periprosthetic osteolysis (PPO), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Dec 2011; status: completed.
02
Drugs
denosumab
03
Conditions
periprosthetic osteolysis (PPO)
Beyond the preview
Go deeper on NCT01358669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358669.